Andrea Remondino
Overview
Explore the profile of Andrea Remondino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
318
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Praz F, Wahl A, Schmutz M, Pfammatter J, Pavlovic M, Perruchoud S, et al.
J Invasive Cardiol
. 2015 Mar;
27(3):157-62.
PMID: 25740969
Objectives: We sought to assess the safety and efficacy of percutaneous closure of atrial septal defects (ASDs) under fluoroscopic guidance only, without periprocedural echocardiographic guidance. Background: Percutaneous closure of ASDs...
2.
Billinger M, Beutler J, Taghetchian K, Remondino A, Wenaweser P, Cook S, et al.
Eur Heart J
. 2008 Feb;
29(6):718-25.
PMID: 18272504
Aims: Percutaneous coronary intervention (PCI) in diabetic patients is associated with an increased risk of restenosis and major adverse cardiac events (MACE). We assessed the impact of diabetes on long-term...
3.
Windecker S, Remondino A, Eberli F, Juni P, Raber L, Wenaweser P, et al.
N Engl J Med
. 2005 Aug;
353(7):653-62.
PMID: 16105989
Background: Sirolimus-eluting stents and paclitaxel-eluting stents, as compared with bare-metal stents, reduce the risk of restenosis. It is unclear whether there are differences in safety and efficacy between the two...
4.
Wenaweser P, Rey C, Eberli F, Togni M, Tuller D, Locher S, et al.
Eur Heart J
. 2005 Feb;
26(12):1180-7.
PMID: 15728650
Aims: To investigate the efficacy and outcome of emergency percutaneous coronary interventions (PCI) in patients with stent thrombosis. Methods And Results: Between 1995 and 2003, 6058 patients underwent bare-metal stent...
5.
Butz S, Driamov S, Remondino A, Bellahcene M, Beier K, Ziegler A, et al.
J Pharm Pharmacol
. 2004 Apr;
56(4):521-8.
PMID: 15099447
Based on clinical and experimental studies, angiotensin II receptor blockers and angiotensin converting enzyme inhibitors have been proposed to exert acute anti-arrhythmic effects in heart failure patients. Therefore, the goal...
6.
Kwon S, Pimentel D, Remondino A, Sawyer D, Colucci W
J Mol Cell Cardiol
. 2003 Jun;
35(6):615-21.
PMID: 12788379
Reactive oxygen species (ROS) can act as signaling molecules to stimulate either hypertrophy or apoptosis in cardiac myocytes. We tested the hypothesis that the phenotypic effects of ROS are due...
7.
Remondino A, Kwon S, Communal C, Pimentel D, Sawyer D, Singh K, et al.
Circ Res
. 2003 Feb;
92(2):136-8.
PMID: 12574140
Stimulation of beta-adrenergic receptors (betaARs) causes apoptosis in adult rat ventricular myocytes (ARVMs). The role of reactive oxygen species (ROS) in mediating betaAR-stimulated apoptosis is not known. Stimulation of betaARs...
8.
Communal C, Colucci W, Remondino A, Sawyer D, Port J, Wichman S, et al.
J Card Fail
. 2002 May;
8(2):86-92.
PMID: 12016632
Background: Mitogen-activated protein kinases (MAPKs), consisting of the ERK1/2, JNKs, and p38-kinase families, play a key role in the regulation of myocyte growth and apoptosis in vitro. The activity of...